Top 5 Healthcare Cost Articles of 2024
One of this year's top articles on cost and coverage highlights that the average American can afford a maximum of $97 in out-of-pocket healthcare expenses.
- HHS Releases Part Two of Medicare Prescription Drug Payment Plan
Part two focuses on the requirement that Part D sponsors must make enrollees aware of upcoming benefits.
Read here - More than a Third of Americans Have Skipped a Healthcare Visit Due to Inability to Pay
The average American can afford a maximum of a $97 for out-of-pocket healthcare expenses.
Read here - Lilly Introduces Zepbound Single-Dose Vial for Cash-Paying Patients
The monthly price of the 2.5 mg Zepbound single-dose vial is $399 and the 5 mg dose is $549, which Lilly officials said is in line with the savings program for without insurance.
Read here - Nonsteroidal Drug for Duchenne Launches with a $700,000 Price Tag
Duvyzat was approved in March 2024 and works to reduce the inflammation and loss of muscle experienced by patients with Duchenne muscular dystrophy.
Read here - Loren McCaghy of Accenture Suggests Digital Engagement, Ease of Use as Key Drivers in Healthcare Provider and Payer Turnover
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen here
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
